Status | Study |
Recruiting |
Study Name: GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia Condition: Leukemia, Acute Lymphoblastic Acute Myeloid Leukemia Date: 2016-06-09 Interventions: Procedure: Allogeneic stem cell transplantation |
Recruiting |
Study Name: HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide Condition: Myelodysplastic Syndrome (MDS) Chronic Lymphocytic Leukemia (CLL) Date: 2016-05-31 Interventions: Drug: Fludarabine |
Not yet recruiting |
Study Name: Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies Condition: Hematologic Malignancy Date: 2016-03-16 Interventions: Drug: Fludarabine |
Recruiting |
Study Name: Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib Tosylate in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Condition: Acute Biphenotypic Leukemia Acute Myeloid Leukemia Date: 2016-03-14 Interventions: Drug: Cladribine Given IV |
Terminated |
Study Name: Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies Condition: Mixed Lineage Acute Leukemia Acute Myeloid Leukemia Date: 2015-04-14 Interventions: Drug: Bortezomib Bortezomib wi |
Recruiting |
Study Name: Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD Condition: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Acut Date: 2014-08-18 Interventions: Procedure: Allogeneic Hematopoietic Stem Cell Transplantation |
Recruiting |
Study Name: Cladribine Plus Idarubicin Plus Cytarabine (ARAC) in Patients With Acute Myeloid Leukemia (AML), High Risk Myelodysplastic Syndrome (HR MDS) or Myeloid Blast Phase of Chronic Myeloid Leukemia (CML) Condition: Leukemia Date: 2014-04-14 Interventions: Drug: Cladribine |
Recruiting |
Study Name: Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes Condition: Acute Biphenotypic Leukemia de Novo Myelodysplastic Syndrome Date: 2014-01-22 Interventions: Drug: Cladribine Given IV |
Recruiting |
Study Name: Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention Condition: Chronic Myelogenous Leukemia Acute Lymphoblastic Leukemia Date: 2013-09-24 Interventions: Drug: tacrolimus Tacrolimus 0. |
Active, not recruiting |
Study Name: Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children Condition: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Acut Date: 2013-05-15 Interventions: Procedure: Allogeneic Hematopoietic Stem Cell Transplantation |